734 A phase 1 study exploring the safety and tolerability of the small-molecule PD-L1 inhibitor, INCB099280, in patients with select advanced solid tumors | Zendy

AI Assistant Blog Pricing

734 A phase 1 study exploring the safety and tolerability of the small-molecule PD-L1 inhibitor, INCB099280, in patients with select advanced solid tumors

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.